Molecular Templates Revenue, Growth & Competitor Profile

DBA THRESHOLD PHARMACEUTICALS, INC.

Company Profile & Annual Report for Molecular Templates

Access the complete profile.

Molecular Templates Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	9301 Amberglen Boulevard Suite 100 Austin, TX 78729

Note: Revenues for privately held companies are statistical evaluations.


Molecular Templates's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Molecular Templates's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Molecular Templates is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Molecular Templates Annual Revenue and Growth Rate

Molecular Templates	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Molecular Templates's revenues are gauged from an analysis of company filings.

Molecular Templates's Income Statement (based on Industry Averages)

Molecular Templates P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Molecular Templates is developing and marketing. Molecular Templates doesn't have any recent trademark applications, indicating Molecular Templates is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
HYPOXIN Pharmaceutical preparations for use in oncology	11/12/2012
THRESHOLD Housemark for a full line of pharmaceutical products; pharmaceutical preparations for the treatment of cancer	03/23/2004
GLUFOS Pharmaceutical products for the treatment of cancer	03/23/2004

See all trademarks and details in the Full Report.

Market Share of Molecular Templates's Largest Competitors

A competitive analysis shows these companies are in the same general field as Molecular Templates, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Molecular Templates. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
FAGRON HOLDING USA	Austin, TX	100
MOLECULAR TEMPLATES	Austin, TX	13
PREMIER RESEARCH LABS	Austin, TX	11
ASPIRA WOMEN'S HEALTH	Austin, TX	4
ORGANICARE NATURE'S SCIENCE	Austin, TX	1
SPEEDX	Austin, TX	0

Future Competition: Molecular Templates's Fastest Growing Competitors

These companies are in the same general field as Molecular Templates and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)